Autopsy report · NCT04321850

Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.

“Health restrictions due to the COVID-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• Ran for about 1 year 2 months before it stopped.
• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

National Institute of Pediatrics, Mexico

Sponsor type

Government (non-US federal)

Conditions

Oral Mucositis

Interventions

Zinc Sulfate 50 Mg Tab; Placebo oral tablet

Participants

21

Sites

1

Countries

Mexico

Trials that died the same way

• High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Bulimia and Anorexia Nervosa
  “COVID-19 pandemic restrictions.” (92% match in meaning)
• Clinical Trial Evaluating the Safety and Efficacy of the Use of Chitosan Gel in Patients With Chronic Wounds
  “COVID-19 restrictions” (84% match in meaning)
• Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)
  “COVID-19 Research Restrictions” (78% match in meaning)
• RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches
  “Covid restrictions” (77% match in meaning)
• Effects of Exercise and Yogurt on Bone Mineral Density and Immunological Factors in Human Milk: The MEEMA Study
  “COVID 19 pandemic” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.